基本信息
views: 20

Bio
The content of our group is molecular design, synthesis, separation, characterization and bioanalytical testing of medicinally active organic substances and their formulations. From the point of view of medical applications, we focus on theranostics, cellular probes, enzymatic, epigenetic and pharmaceuticals. Molecular design is based on organic substances based on the structural motif of, for example, hydrazones, methinium salts, coumarins, curcumins, Troger's bases, etc.
Research Interests
Papers共 66 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER LETTERS (2025)
Frontiers in immunology (2025): 1479483-1479483
Markéta Skaličková, Nikita Abramenko, Tatsiana Charnavets, Frédéric Vellieux, Jindřiška Leischner Fialová,Kateřina Kučnirová,Zdeněk Kejík,Michal Masařík, Pavel Martásek,Karel Pacak, Tomáš Pacák,Milan Jakubek
ACS omegano. 16 (2025): 15935-15946
Ivana Kawiková, Václav Špička, James C K Lai, Philip W Askenase,Li Wen,Zdeněk Kejík,Milan Jakubek,Karel Valeš,Filip Španiel
Nikola Odehnalová, Viera Šandriková, Róbert Hromadka,Markéta Skaličková, Petr Dytrych,David Hoskovec,Zdeněk Kejík,Jan Hajduch, Frédéric Vellieux, Martina Koziar Vašáková, Pavel Martásek,Milan Jakubek
Frontiers in medicine (2025): 1539714-1539714
SCIENTIFIC REPORTSno. 1 (2024)
JOURNAL OF CLINICAL MEDICINEno. 4 (2024)
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2024): 117407-117407
Redox Reportno. 1 (2024)
FRONTIERS IN MEDICINE (2024)
Load More
Author Statistics
#Papers: 66
#Citation: 821
H-Index: 16
G-Index: 27
Sociability: 5
Diversity: 3
Activity: 43
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn